- Lindus Health Launches “All-In-One Metabolic CRO” Offering to Accelerate and Enhance Metabolic Clinical Trials
- Haemonetics Announces Definitive Agreement to Acquire Attune Medical
- Synexa Life Sciences Expands Biomarker Discovery Capabilities with the Addition of Olink® Target Platform
- Bone Health Technologies Raises $5M to Launch Bone Density Wearable
- Nektar Therapeutics Announces $30 Million Private Placement Financing with TCGX
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States, Medical Device News Magazine has established itself as one of the foremost and most trusted sources of comprehensive updates and insights within the medical device and biotech industries. Our publication is committed to delivering timely and relevant information, making it a go-to resource for professionals and enthusiasts alike.
Medical Device News Magazine is easily accessible to readers 24/7/365, allowing you to stay informed at your convenience, and it presents content that is a fast and engaging read. We take pride in offering valuable insights in a format that can be consumed quickly, ensuring that our audience stays ahead of the curve.
Furthermore, if you are interested in expanding your reach and visibility within this dynamic field, we encourage you to inquire about advertising opportunities with us.
"Medical Device and Biotechnology Sector News: Essential Key Insights and Noteworthy Developments that are Shaping the Future"
AliveCor Collaborates with European Market Leader in Remote Patient Monitoring Luscii to Offer World’s First ‘Virtual Heart Clinic in a Box’
Together, the companies will launch the world’s first ‘virtual heart clinic in a box’, revolutionising cardiac care for millions of patients by making it easy for any hospital or GP to deliver high-quality, remote patient monitoring to their patients.
Magenta Medical Reports 1st Patients Treated in the US with the World’s Smallest Heart Pump
“Magenta Medical CEO Dr. David Israeli, CEO said, “Magenta is proud to partner with top cardiology centers in the United States to further the validation of its technology and provide cardiologists with a powerful tool to support their high-risk patients during complex procedures. We are looking forward to a speedy recruitment process and favorable study outcomes that would allow us to take the next step in the clinical program towards ultimate market approval.”
Laird Thermal Systems Unveils Micro Multistage Thermoelectric Cooler & Optical TEAs Integration Capability
“Advanced process automation has enabled a new level of miniaturization for our MSX multistage series to support next-generation imaging solutions that require smaller optical packages,” said Andrew Dereka, Thermoelectrics Product Director at Laird Thermal Systems
Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring
Currently, there are no medical-grade, commercially available, non-invasive glucose monitoring devices. The completion of Gen 1 brings Know Labs closer to achieving its ultimate goal of delivering the world’s first FDA-cleared non-invasive blood glucose monitor for the billions of people living with diabetes and pre-diabetes worldwide.
Innovative Solutions for Today's Challenges, Secured Funding for a Brighter Future
Cresilon Closes $25 Million in Series A-4 Financing to Accelerate Global Expansion and Bring Revolutionary Hemostatic Gel to Human Health Market
Cresilon advises the financing will support the company’s efforts to aggressively accelerate its global expansion plan and bring its revolutionary hemostatic gel to the human health market.
Monteris Medical Announces $73 Million in Combined Equity and Debt Financing
Monteris Medical notes the proceeds of this financing will be used to continue to support the rapid adoption of the NeuroBlate® System, an MR-guided laser ablation system that allows for a minimally invasive surgical alternative to open craniotomies.
Industry Expert Byline
Reimagining CRM: What’s Next for Medtech Commercial Success | By Akshay Kapadia, CEO and Founder, Conexus Solutions, Inc.
Success depends on more than just choosing the right CRM platform; it requires aligning that platform with optimized business processes, a clear data strategy, and long-term commercial goals. When all of these elements work together, the CRM platform becomes a powerful tool to support growth, innovation, and sustained value.
EMA’s CHMP Positive for Arpraziquantel to Treat Schistosomiasis in Preschool-Aged Children
EMA assessed arpraziquantel under the EU-M4all procedure for high-priority medicines intended for use in countries outside the European Union. Merck KGaA, Darmstadt, Germany, is committed to contribute to the elimination of schistosomiasis as a public health problem by 2030.
NMDP/Be The Match® PTCy Research Levels the Field between Matched and Mismatched Hematopoietic Cell Transplantation
Research shows no discernable differences in graft versus host disease, relapse free survival or overall survival for patients who had a Hematopoietic Cell Transplant (HCT) with an 8/8 or 7/8 Unrelated Donor (URD) for adult patients with malignancies.
Comprehensive Insights into Medical Device and Biotechnology Company Mergers and Acquisitions Trends and Strategies
Medtronic to Acquire Intersect ENT
The acquisition is expected to close toward the end of Medtronic’s current fiscal year, subject to the satisfaction of customary closing conditions, including receipt of regulatory clearances and approval by Intersect ENT’s stockholders.
Experien Group Acquired by Veranex
Veranex combines product development, regulatory, and market access expertise — globally and across complex and emerging markets.
FDA Medical Device Updates
Our Experts - Byline Articles
Medical Imaging Technologies and Their Impact on Modern Healthcare
Healing Headlines, Transforming Lives: Hospitals in the News
GE HealthCare Advances PET/MR Capabilities with AIR Technologies
Jie Xue, President and CEO of MR at GE HealthCare. “Our latest PET/MR technology will directly impact the most challenging diseases, such as prostate cancer and Alzheimer’s Disease. These diseases require precise and comprehensive imaging for accurate diagnosis, treatment planning, and therapy monitoring. We are excited to see SIGNA PET/MR AIR addressing these challenges and fulfilling our vision of providing access to advanced, personalized care.”
